XETRA •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 07/29/2026 17:35
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeXETRA
Market Capitalization621.93 mln
Float133 mln
Earnings Date08/13/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-3.42
Reliable
1-Year Forecast
4.90
Exceptional upside
Relative Strength
33
/ 100
Underperforming
Debt / Equity
0.55
Moderate leverage
ROE
-23.81
Deeply negative
Business Description
Evotec SE is a Hamburg-based drug research and development company founded in 1993, operating across the United States, Europe, and other global markets. The company works to discover and develop treatments for a wide range of serious conditions, including cancer, diabetes, heart disease, kidney and liver disorders, and rare diseases, among others. Evotec partners with leading universities, hospitals, research centers, and pharmaceutical companies worldwide to advance its pipeline, and also serves biotech firms, patient groups, and academic institutions.
